● Recruiting

Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)

Condition: Alzheimer's Dementia · Sponsor: Sichuan Jishengtang Pharmaceutical Co., Ltd.

PhasePhase 3

Planned participants570

Who can joinAll sexes, 50 Years to 80 Years

Healthy volunteersNo

About this study

This study is a randomized, double-blind, placebo-controlled phase 3 design aimed at further verifying the safety and efficacy of Wujia Yizhi granules for mild-to-moderate Alzheimer's dementia

This description comes directly from the study's public registry record.

Talk to the study team

Lin song · 028-81258178 · 022516@cnkh.com

Always discuss trial participation with your own doctor first.

Locations (1)

Fujian Medical University Affiliated Union Hospital

Fuzhou, Fujian, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06534723